Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Tepotinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Approves FoundationOne®Liquid CDx for TEPMETKO® in NSCLC Cancer
    FDA Approves FoundationOne®Liquid CDx for TEPMETKO® in NSCLC Cancer

    18 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241118083116/en

    BUSINESSWIRE
    18 Nov 2024
    Share Share
    Merck to Highlight Data at ESMO with Potential for Impact on Cancer Patients
    Merck to Highlight Data at ESMO with Potential for Impact on Cancer Patients

    07 Sep 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220907005443/en

    BUSINESSWIRE
    07 Sep 2022
    Share Share
    Merck Europe B.V. Tepmetko(tepotinib) Receives Approval in Europe
    Merck Europe B.V. Tepmetko(tepotinib) Receives Approval in Europe

    05 May 2022

    // EMA

    https://www.ema.europa.eu/en/documents/overview/tepmetko-epar-medicine-overview_en.pdf

    EMA
    05 May 2022
    Share Share
    EC Approves TEPMETKO in Advanced NSCLC with METex14 Skipping Alterations
    EC Approves TEPMETKO in Advanced NSCLC with METex14 Skipping Alterations

    18 Feb 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220217005798/en

    BUSINESSWIRE
    18 Feb 2022
    Share Share
    TEPMETKO Receives Positive CHMP Opinion in Advanced NSCLC
    TEPMETKO Receives Positive CHMP Opinion in Advanced NSCLC

    17 Dec 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211216005685/en

    BUSINESSWIRE
    17 Dec 2021
    Share Share
    MHRA backs Merck’s MET inhibitor Tepmetko
    MHRA backs Merck’s MET inhibitor Tepmetko

    13 Oct 2021

    // Lucy Parsons PHARMATIMES

    https://www.pharmatimes.com/news/mhra_backs_mercks_met_inhibitor_tepmetko_1380739

    Lucy Parsons PHARMATIMES
    13 Oct 2021
    Share Share